Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Sep 15, 2017 4:32pm
483 Views
Post# 26703183

RE:RE:Did I see right?

RE:RE:Did I see right? There's a pretty good chance we are seeing at least one of the big shorts sittin on the bid and taking back some stock here

I mentioned previously that the mgmt team along with at least one board member were in NY last week listening to Investment Bank pitches with a pretty broad mandate of things, not the least of which is the IP monetization / parternship / Voucher monetization issue.  Not 100% sure but believ they met with Goldman ,JP Morgan, Morgan Stanley and Cantor

The guys also met with at least two very large Health care focussed funds interestsd in the company.

On the back of that, i  find  it interesting to see Goldman Sachss on the net buy side all week, albeit relatively small so far.

You gotta think there's a really good chance of seeing Cantor research initiation any time now. 

Oh its SO painful waiting with so much stuff so imminent!!
Bullboard Posts